USD
+$0.00
(+0.00%
)At Close (As of Sep 26, 2025)
$16.61M
Market Cap
-
P/E Ratio
-0.05
EPS
$32.00
52 Week High
$0.50
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $381K |
Total Revenue | $448K |
Cost Of Revenue | $67K |
Costof Goods And Services Sold | $67K |
Operating Income | -$770K |
Selling General And Administrative | $751K |
Research And Development | $93K |
Operating Expenses | $1.2M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $72K |
Income Before Tax | -$639K |
Income Tax Expense | $22K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$661K |
Comprehensive Income Net Of Tax | - |
Ebit | -$662K |
Ebitda | -$590K |
Net Income | -$661K |
Field | Value (USD) |
---|---|
Total Assets | $6.7M |
Total Current Assets | $6.7M |
Cash And Cash Equivalents At Carrying Value | $6.2M |
Cash And Short Term Investments | $6.2M |
Inventory | $117K |
Current Net Receivables | $308K |
Total Non Current Assets | $46K |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $490 |
Other Non Current Assets | - |
Total Liabilities | $539K |
Total Current Liabilities | $539K |
Current Accounts Payable | $10K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $248K |
Total Non Current Liabilities | $0 |
Capital Lease Obligations | $0 |
Long Term Debt | - |
Current Long Term Debt | $248K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $248K |
Other Current Liabilities | $102K |
Other Non Current Liabilities | - |
Total Shareholder Equity | $6.2M |
Treasury Stock | - |
Retained Earnings | -$523K |
Common Stock | $1.4K |
Common Stock Shares Outstanding | $13M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$775K |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $72K |
Capital Expenditures | $861 |
Change In Receivables | - |
Change In Inventory | -$68K |
Profit Loss | - |
Cashflow From Investment | -$861 |
Cashflow From Financing | $6.7M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $0 |
Dividend Payout Common Stock | $0 |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$661K |
Field | Value (USD) |
---|---|
Gross Profit | $381K |
Total Revenue | $448K |
Cost Of Revenue | $67K |
Costof Goods And Services Sold | $67K |
Operating Income | -$770K |
Selling General And Administrative | $751K |
Research And Development | $93K |
Operating Expenses | $1.2M |
Investment Income Net | - |
Net Interest Income | - |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $72K |
Income Before Tax | -$639K |
Income Tax Expense | $22K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$661K |
Comprehensive Income Net Of Tax | - |
Ebit | -$662K |
Ebitda | -$590K |
Net Income | -$661K |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Pheton Holdings Ltd Class A Ordinary Shares is a leading healthcare solutions provider specializing in innovative treatment software and devices specifically designed for brachytherapy, a form of radiation therapy. The company focuses on advancing cancer treatment technologies, enhancing patient outcomes through precise and efficient therapeutic solutions. With a commitment to research and development, Pheton aims to position itself at the forefront of the healthcare technology sector, capitalizing on the growing demand for effective cancer therapies.